Exelixis
EXEL
#1813
Rank
ยฃ8.34 B
Marketcap
ยฃ31.11
Share price
-1.36%
Change (1 day)
11.24%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company